Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06081426 · ClinicalTrials.gov registry record · NA
Examining Neurobiological Mechanisms Underlying the Therapeutic Effect of the Ketogenic Diet in Bipolar Disorder (BD)
A NA study of Bipolar Disorder, sponsored by University of Pittsburgh.
- Recruiting
- Registry status
- NA
- Development phase
- 107
- Enrollment target
- 1
- Study location
NCT06081426: Recruiting NA study of Bipolar Disorder, sponsored by University of Pittsburgh.
NCT06081426 is a NA study of Bipolar Disorder that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 107 participants, below the 332-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (68% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06081426, a NA study of Bipolar Disorder, is actively recruiting participants, sponsored by University of Pittsburgh.
- RECRUITING
- Registry status
- NA
- Development phase
- 107 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators aim to examine the effect of the ketogenic diet on brain activity, metabolism, and emotions in adults with Bipolar Disorder (BD).
Primary Outcome
The blood oxygen level-dependent (BOLD) signal indicates brain activity and connectivity
Conditions Studied
Interventions
- OTHER Ketogenic Diet
- OTHER Non-ketogenic Diet
- OTHER No diet
Study Locations (1)
Pennsylvania
- University of Pittsburgh Medical Center - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 107 participants |
| Start Date | 2024-01-12 |
| Est. Completion | 2027-01 |
| Phase | NA |
What NCT06081426 shows while recruiting
NCT06081426 is an interventional study that assigns participants to a tested intervention. The registered 107 participants enrollment target is mid-sized for trials with a published cap, below the 332-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (68% lower).
The record links to 1 condition, with Bipolar Disorder appearing as the primary indexed condition, and to 3 interventions - of which Ketogenic Diet is the first listed.
NCT06081426 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06081426 about?
NCT06081426 is a clinical study titled "Examining Neurobiological Mechanisms Underlying the Therapeutic Effect of the Ketogenic Diet in Bipolar Disorder (BD)". The investigators aim to examine the effect of the ketogenic diet on brain activity, metabolism, and emotions in adults with Bipolar Disorder (BD).
What is the current status of trial NCT06081426?
This trial is currently recruiting. It is a NA study. The enrollment target is 107 participants. The study started on 2024-01-12. Estimated completion is 2027-01.
What conditions does trial NCT06081426 study?
This clinical trial studies the following conditions: Bipolar Disorder.
What interventions are being tested in trial NCT06081426?
The interventions under investigation include: Ketogenic Diet (OTHER), Non-ketogenic Diet (OTHER), No diet (OTHER).
Who is sponsoring clinical trial NCT06081426?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06081426 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bipolar Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06081426's enrollment target sits among peer trials
107 63rd of 162 higher than 99 of 162 other Bipolar Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Bipolar Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Taking Action for College Students
RECRUITING · NA
-
Getting Out of the House: Using Behavioral Activation to Increase Community Participation
RECRUITING · NA
-
Intermittent Theta Burst Stimulation (iTBS) for Emotion Regulation in Bipolar Disorder
RECRUITING · NA
-
Healthy Lifestyles in Bipolar Disorder: Bay Area Study
RECRUITING · NA
-
A Future Thinking Intervention for Comorbid Tobacco Use Disorder and Bipolar Disorder
RECRUITING · NA
-
Use of Ketosis in Modulating Metabolic Pathways in Bipolar Disorder
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05491668 · 107 participants
Physiological Assessment of Severe Coronary Stenosis for Informing Planned PCI
- NCT06041594 · 107 participants · NA
Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST)
- NCT06527599 · 107 participants · NA
Screening in Trauma for Opioid Misuse Prevention - an Adaptive Intervention
- NCT07096193 · 107 participants · Phase 1
Study of GS-4321 in Healthy Participants and Participants With Chronic Hepatitis Delta Virus
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI